UY27504A1 - IMIDAZOPIRIDIN COMPOUNDS AS 5-HT4 RECEIVER MODULATORS - Google Patents

IMIDAZOPIRIDIN COMPOUNDS AS 5-HT4 RECEIVER MODULATORS

Info

Publication number
UY27504A1
UY27504A1 UY27504A UY27504A UY27504A1 UY 27504 A1 UY27504 A1 UY 27504A1 UY 27504 A UY27504 A UY 27504A UY 27504 A UY27504 A UY 27504A UY 27504 A1 UY27504 A1 UY 27504A1
Authority
UY
Uruguay
Prior art keywords
disease
compounds
dyspepsia
disorder
imidazopiridin
Prior art date
Application number
UY27504A
Other languages
Spanish (es)
Inventor
David R Fenwick
Geoffrey E Gymer
Hirohide Noguchi
Alan Stobie
Chikara Uchida
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to UY27504A priority Critical patent/UY27504A1/en
Publication of UY27504A1 publication Critical patent/UY27504A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos novedosos de imidazopirina que muestran actividad por unión al receptor 5-HT4 (p.e.actividades agonista o antagonista) y por ende de utilidad en tratamiento o prevención de enfermedad por reflujo gastroesofágico, enfermedad gastrointestinal, trastorno de motilidad gástrica, dispepsia no ulcerosa, dispepsia funcional, síndrome del intestino irritable, estrenimiento, dispepsia, sofagitis, enfermedad gastroesofágica, nauseas, enfermedad en el sistema nervioso central, enfermedad de alzheimer, trastorno cognitivo, emesis, migrana, enfermedad neurológica, dolor, ictus isquémico, ansiedad, trastorno cardiovascular o similares, en mamíferos, especialmente en el ser humano. También refiere una composición farmacéutica que comprende los compuestos anteriores.Novel imidazopyrine compounds that show activity by binding to the 5-HT4 receptor (agonist or antagonistic activities) and therefore useful in the treatment or prevention of gastroesophageal reflux disease, gastrointestinal disease, gastric motility disorder, non-ulcer dyspepsia, functional dyspepsia , irritable bowel syndrome, constipation, dyspepsia, sofagitis, gastroesophageal disease, nausea, central nervous system disease, Alzheimer's disease, cognitive disorder, emesis, migraine, neurological disease, pain, ischemic stroke, anxiety, cardiovascular disorder or the like, in mammals, especially in humans. It also refers to a pharmaceutical composition comprising the above compounds.

UY27504A 2002-10-18 2002-10-18 IMIDAZOPIRIDIN COMPOUNDS AS 5-HT4 RECEIVER MODULATORS UY27504A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27504A UY27504A1 (en) 2002-10-18 2002-10-18 IMIDAZOPIRIDIN COMPOUNDS AS 5-HT4 RECEIVER MODULATORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27504A UY27504A1 (en) 2002-10-18 2002-10-18 IMIDAZOPIRIDIN COMPOUNDS AS 5-HT4 RECEIVER MODULATORS

Publications (1)

Publication Number Publication Date
UY27504A1 true UY27504A1 (en) 2003-06-30

Family

ID=38812706

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27504A UY27504A1 (en) 2002-10-18 2002-10-18 IMIDAZOPIRIDIN COMPOUNDS AS 5-HT4 RECEIVER MODULATORS

Country Status (1)

Country Link
UY (1) UY27504A1 (en)

Similar Documents

Publication Publication Date Title
UY29421A1 (en) NEW COMPOUNDS OF N- (N-SULFONYLAMINOARILMETIL) CYCLOPROPANOCARBOXANIDA SUBSTITUTED, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM TO APPLICATIONS.
UY28496A1 (en) BENCIMIDAZOLONE COMPOUNDS THAT HAVE AGENIST ACTIVITY OF THE RECEIVER 5-HT4
DOP2006000046A (en) OXINDOL DERIVATIVES
AR041302A1 (en) IMIDAZOPIRIDINE COMPOUNDS AS RECEIVER AGONISTS 5- HT4 AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH COMPOUNDS
ECSP067079A (en) BENCIMIDAZOLONA CARBOXYL ACID DERIVATIVES
TW200621245A (en) Thienopyridinone compounds and methods of treatment
BRPI0510022A (en) thienopyridinone compounds and treatment processes
CA2559530C (en) Novel benzyl(idene)-lactam derivatives
UY26662A1 (en) COMPOUNDS CONTAINING BENZAMIDO-PIPERIDINE AND RELATED COMPOUNDS.
EE04279B1 (en) Crystalline form of omeprazole
NO20064579L (en) Biphenyl compounds useful as muscarinic receptor antagonists
ATE449092T1 (en) INDAZOLE CARBONIC ACID AMIDE DERIVATIVES AS AGONISTS OF THE 5HT4 RECEPTOR
HK1100290A1 (en) Heterocyclic condensed compounds useful as antidiuretic agents
EA200601895A1 (en) 3- (4-HETEROAARYLCYCLOGEXYLAMINO) CYCLOPENTANKARBOXAMIDES AS CHEMOKIN RECEPTOR MODULATORS
EA200501595A1 (en) AZABICYCLIC DERIVATIVES AS ANTAGONISTS OF MUSCARINE RECEPTOR
PE20050726A1 (en) DERIVATIVES OF 1-SULFONILINDOLES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINES
DE60213629D1 (en) Piperidin compounds as muscarinic agonists
ECSP077230A (en) TRICYCLE DELTA-OPIOID MODULATORS
UY27504A1 (en) IMIDAZOPIRIDIN COMPOUNDS AS 5-HT4 RECEIVER MODULATORS
DOP2004000986A (en) BENCIMIDAZOLONE COMPOUNDS THAT HAVE 5HT-4 RECEIVER ACTIVITY
SE0403005D0 (en) New use
CU20070183A7 (en) OXINDOL DERIVATIVES
PE20040894A1 (en) MUSCARINE AGONISTS
DOP2005000113A (en) BENCIMIDAZOLONA CARBOXILIC ACID DRIVATES
UA87845C2 (en) Thienopyridinone compounds and methods of treatment of nervous system disorders

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150126